20(R) -ginsenoside Rg3PI3K/Akt/mTOR,-

Daiju Tao1, Fajing Li2, Xiaochao Zhang1

  • 1School of Pharmaceutical Science, Yunnan Key Laboratory of Pharmacology for Natural Products, NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, 650500, PR China.

Neuropharmacology
|November 18, 2024
PubMed
概括

在大脑缺血再输血后,R-ginsenoside Rg3治疗显著减少了大脑损伤,并改善了大脑缺血再输血后大鼠的运动功能. 这种神经保护作用通过通过PI3K/Akt/mTOR途径抑制自来实现.

相关概念视频